@inproceedings{inproceedings, title = {{A cost-utility analysis of nilotinib for CML patients who have become resistant to imatinib}},
url = {{}},
year = {{2008}},
month = {{4}},
author = {{Jewitt K and Pilgrim H and Ward S}},
volume = {{141}},
journal = {{BRITISH JOURNAL OF HAEMATOLOGY}},
pages = {{38-38}},
note = {{Accessed on 2025/05/31}}}